Basis and Purpose - 4-125
The statutory authority for this rule includes but is not
limited to sections
44-10-202(1)(c),
44-10-203(1)(a),
44-10-203(1)(c),
44-10-203(1)(g),
44-10-203(1)(k),
44-10-203(2)(d),
44-10-203(2)(f),
44-10-203(3)(d),
44-10-203(3)(e),
44-10-501(6),
44-10-502(3),
44-10-503(8),
44-10-504(1)(b),
44-10-504(2),
44-10-601(4),
44-10-602(4),
44-10-603(6),
44-10-604(1)(b),
and 44-10-604(2),
C.R.S. Authority also exists in the Colorado Constitution at Article XVIII,
Subsection 16(5)(a)(VII). The purpose of this rule is to protect the public
health and safety by establishing the potency testing and related Reduced
Testing Allowance portion of the Division's Regulated Marijuana sampling and
testing program. This Rule 4-125 was previously Rules M and R 1503,
1 CCR
212-1 and
1 CCR
212-2.
A.
Potency Testing - General.
1.
Test Batches. A
Test Batch submitted for potency testing may only be comprised of sample
increments that are of the same strain of Medical Marijuana or Retail Marijuana
or from the same Production Batch of Medical Marijuana Concentrate or Medical
Marijuana Product, or from the same Production Batch of Retail Marijuana
Concentrate or Retail Marijuana Product, or from the same Production Batch of
Pre-Rolled Marijuana or Infused Pre-Rolled Marijuana.
2.
Cannabinoid
Profile. A potency test conducted pursuant to this Rule must at
least determine the level of concentration of D8-THC, D9-THC, D-10 THC,
Exo-THC, THCA, CBD, CBDA, and CBN.
B.
Potency Testing for Regulated
Marijuana.
1.
Initial
Potency Testing. A Regulated Marijuana Cultivation Facility must
have potency tests conducted by a Regulated Marijuana Testing Facility on four
Harvest Batches, created a minimum of one week apart, for each strain of
Regulated Marijuana that it cultivates.
See Rule 4-105(B).
a. The first potency test must be conducted
on each strain prior to the Regulated Marijuana Cultivation Facility
Transferring or processing into a Medical Marijuana Concentrate any Medical
Marijuana of that strain, or into a Retail Marijuana Concentrate any Retail
Marijuana of that strain.
b. All
four potency tests must be conducted on each strain no later than December 1,
2014 or six months after the Regulated Marijuana Cultivation Facility begins
cultivating that strain, whichever is later.
2.
Ongoing Potency
Testing. After the initial four potency tests, a Regulated
Marijuana Cultivation Facility shall have each strain of Regulated Marijuana
that it cultivates tested for potency at least once per quarter.
a. If the Licensee fails to comply with
paragraph (B)(2) of this Rule, the Regulated Marijuana Cultivation Facility is
no longer authorized for a Reduced Testing Allowance.
C.
Potency Testing for
Regulated Marijuana Concentrate except Kief.
1. A Medical Marijuana Cultivation Facility
or a Medical Marijuana Products Manufacturer must have a potency test conducted
by a Medical Marijuana Testing Facility on every Production Batch of Medical
Marijuana Concentrate that it produces prior to Transferring or processing into
a Medical Marijuana Product any of the Medical Marijuana Concentrate from that
Production Batch.
2. A Retail
Marijuana Cultivation Facility, Accelerator Cultivator, Retail Marijuana
Products Manufacturer, or an Accelerator Manufacturer must have a potency test
conducted by a Retail Marijuana Testing Facility on every Production Batch of
Retail Marijuana Concentrate that it produces prior to Transferring or
processing into a Retail Marijuana Product any of the Retail Marijuana
Concentrate from that Production Batch.
D. Repealed.
E.
Potency Testing for Regulated
Marijuana Product.
1.
Potency Testing Required for Regulated Marijuana
Product. A Regulated Marijuana Products Manufacturer shall have
potency tests conducted by a Regulated Marijuana Testing Facility on every
Production Batch of each type of Regulated Marijuana Product that it produces
prior to Transferring any of the Regulated Marijuana Product from that
Production Batch, unless the Regulated Marijuana Products Manufacturer has
successfully achieved a Reduced Testing Allowance for potency and homogeneity
for the particular type of Regulated Marijuana Product.
2.
Required Tests.
Potency and homogeneity tests conducted on Regulated Marijuana Product must
determine the level of concentration of the required Cannabinoids and whether
or not THC is homogeneously distributed throughout the product.
3.
Partially Infused Regulated
Marijuana Products. If only a portion of a Regulated Marijuana
Product is infused with Regulated Marijuana, then the Regulated Marijuana
Products Manufacturer must inform the Regulated Marijuana Testing Facility of
exactly which portions of the Regulated Marijuana Product are infused and which
portions are not infused.
E.1.
Potency Testing Required for
Pre-Rolled Marijuana.
1. A
Regulated Marijuana Business shall have potency tests conducted by a Regulated
Marijuana Testing Facility on every Production Batch of each type of Pre-Rolled
Marijuana product that it produces prior to Transferring or selling any of the
Pre-Rolled Marijuana from that Production Batch if the Regulated Marijuana
Business is using multiple strains from different sources (e.g. self-grown
source, wholesale source) and/or selecting only a part of the Harvest Batch(es)
that is not representative of the entire Harvest Batch each time they produce a
certain type of Pre-Rolled Marijuana (e.g. using only the shake/trim out of a
Harvest Batch).
2. If each type of
Pre-Rolled Marijuana is created Using select parts of a single strain (e.g.
flower only, shake/trim only) or a specific ratio of strains from specified
sources (e.g. self-grown source, wholesale source) defined by the Regulated
Marijuana Business' standard operating procedures, a Regulated Marijuana
Business shall have potency tests conducted according to paragraph (E.1)(2)(a)
and (b) of this Rule by a Regulated Marijuana Testing Facility for each type of
Pre-Rolled Marijuana product that it produces prior to Transferring or selling
any of the Pre-Rolled Marijuana from a Production Batch.
a.
Initial Potency
Testing. Initial potency tests shall be conducted by a Regulated
Marijuana Testing Facility on four Production Batches, created a minimum of one
week apart, for each type of Pre-Rolled Marijuana that is created using a
single strain or a specific ratio of strains defined by the Regulated Marijuana
Business' standard operating procedures.
b.
Ongoing Potency
Testing. After the initial four potency tests, ongoing potency
tests shall be conducted by a Regulated Marijuana Testing Facility at least
once per quarter for each type of Pre-Rolled Marijuana that is created using a
single strain or a specific ratio of strains defined by the Regulated Marijuana
Business' standard operating procedures.
3. A Regulated Marijuana Business shall be
considered exempt from potency testing if the Pre-Rolled Marijuana Production
Batch uses a single strain and uses all parts of the Harvest Batch that were
included in the potency testing of the Harvest Batch prior to creating the
Pre-Rolled Marijuana Production Batches. In this case, the potency test results
of the Harvest Batch shall be used for the Pre-Rolled Marijuana Production
Batch.
4. Production Batches of
Pre-Rolled Marijuana are exempt from homogeneity testing.
E.2.
Potency Testing Required for
Infused Pre-Rolled Marijuana.
1.
A Regulated Marijuana Business shall have potency tests conducted by a
Regulated Marijuana Testing Facility on every Production Batch of Infused
Pre-Rolled Marijuana product that it produces prior to Transferring any of the
Infused Pre-Rolled Marijuana from that Production Batch.
2. Production Batches of Infused Pre-Rolled
Marijuana are exempt from homogeneity testing.
F.
Reduced Testing Allowance -
Potency and Homogeneity.
1. A
Retail Marijuana Products Manufacturer or Accelerator Manufacturer may achieve
a Reduced Testing Allowance for potency and homogeneity for each type of Retail
Marijuana Product it manufactures.
a. For
Edible Retail Marijuana Products a potency test result that is within 15
percent of the target potency will count towards a Reduced Testing Allowance.
i. For Edible Retail Marijuana Products that
contain 2.5 milligrams of THC or less per serving, a potency test result that
is within the greater of plus or minus 0.5 milligrams or 40 percent per serving
will count towards a Reduced Testing Allowance.
2. A Medical Marijuana Products Manufacturer
may achieve a Reduced Testing Allowance for potency and homogeneity for each
type of non-Edible Medical Marijuana Product and each type of Edible Medical
Marijuana Product that it manufactures.
a.
For Edible Medical Marijuana Products that contain 100 milligrams of THC or
less per Container, a potency test result that is within 15 percent of the
target potency will count towards a Reduced Testing Allowance.
i. For Edible Medical Marijuana Products that
contain 2.5 milligrams of THC or less per serving and less than 100 milligrams
of THC per Container, a potency test result that is within the greater of plus
or minus 0.5 milligrams or 40 percent per serving will count towards a Reduced
Testing Allowance.
b. For
Edible Medical Marijuana Products that contain between 101 and 500 milligrams
of THC per Container, a potency test result that is within 10 percent of the
target potency will count towards a Reduced Testing Allowance.
c. For Edible Medical Marijuana Products that
contain 501 milligrams of THC or more per Container, a potency test result that
is within 5 percent of the target potency will count towards a Reduced Testing
Allowance.
3. A Regulated
Marijuana Products Manufacturer's production process for a particular type of
Regulated Marijuana Product shall be deemed acceptable for a Reduced Testing
Allowance for potency and homogeneity testing if every Production Batch that it
produces for that particular type of Regulated Marijuana Product during at
least a four-week period but no longer than an eight-week period passes all
potency and homogeneity tests required by Rule 4-125. This must include at
least four Test Batches.
4.
Expiration of a Reduced Testing Allowance. A Regulated
Marijuana Products Manufacturer is required to achieve a new Reduced Testing
Allowance every 12 months from the date the Reduced Testing Allowance is
achieved (365 days inclusive, or 366 days inclusive during a leap year from the
date of the first Production Batch utilized to initiate establishing a Reduced
Testing Allowance), after which point the Reduced Testing Allowance expires.
When the Reduced Testing Allowance expires, the Regulated Marijuana Business
shall comply with the requirements of this Rule.
5.
Regulated Marijuana Product
Ongoing Potency and Homogeneity Testing. After successfully
achieving a Reduced Testing Allowance, once per quarter a Regulated Marijuana
Products Manufacturer shall subject at least one Production Batch of each type
of Medical Marijuana Product or Retail Marijuana Product that it produces to
potency and homogeneity testing required by Paragraph (D) of this Rule. If
during any quarter the Regulated Marijuana Products Manufacturer does not
possess a Production Batch that is ready for testing, the Licensee must subject
its first Production Batch that is ready for testing to the required potency
and homogeneity testing prior to Transfer or processing of the Regulated
Marijuana. If a Test Batch submitted for ongoing potency and homogeneity
testing fails potency and homogeneity testing, the Licensee shall follow the
procedure in Paragraph (H) of this Rule. Ongoing potency and homogeneity
testing pursuant to this Rule 4-125 shall be subject to the requirements in
Rule 4-110.
See Rule 4-110(A) - Collection of Test Batches.
a. The Division may reduce the frequency of
ongoing potency and homogeneity testing required if the Division has reasonable
grounds to believe Medical Marijuana Testing Facilities and Retail Marijuana
Testing Facilities have reached maximum capacity to perform testing required by
this Rule. The Division will provide notification of any reduction to the
frequency of ongoing potency and homogeneity testing to the Licensee's last
electronic mailing address provided to the Division.
b. If the Licensee fails to comply with
paragraph (F)(5) of this Rule, the Regulated Marijuana Cultivation Facility is
no longer authorized for a Reduced Testing Allowance.
G.
Exemption. Any Regulated Marijuana that will be
allocated for extraction in the Inventory Tracking System shall be considered
exempt from potency testing pursuant to this Rule.
H.
Events Requiring
Re-Authorization for a Reduced Testing Allowance - Potency and Homogeneity -
Regulated Marijuana Product.
1.
Material Change. If a Regulated Marijuana Products
Manufacturer elects to achieve a Reduced Testing Allowance for any Regulated
Marijuana Products for potency and homogeneity and it makes a Material Change
to its production process for that particular type of Regulated Marijuana
Product, then the Regulated Marijuana Products Manufacturer shall achieve a new
Reduced Testing Allowance.
a.
New
Equipment. It is a Material Change if the Regulated Marijuana
Products Manufacturer begins using new or different equipment for any material
part of the production process.
b.
Repealed.
c.
Testing Required Prior to
Transfer. When a Production Batch is required to be submitted for
testing pursuant to this Rule, the Regulated Marijuana Products Manufacturer
that produced it may not Transfer Regulated Marijuana Product from that
Production Batch unless it obtains a passing test.
2.
Failed Potency
Testing. Failed potency testing may constitute a violation of
these rules.
a. If a Test Batch is required to
be tested by these Rules or required to be tested by the Division pursuant to
Rule 4-115(A) and fails potency testing, the Regulated Marijuana Products
Manufacturer shall follow the procedures in Rule 4-135(E) for any Inventory
Tracking System package or Production Batch associated with the failed
Sample.
b. The Regulated Marijuana
Products Manufacturer shall also submit Test Batches from three new Production
Batches of the Regulated Marijuana Product t for potency testing by a Regulated
Marijuana Testing Facility within no more than 30 days. If any one of the three
submitted Test Batches fails potency testing, the Regulated Marijuana Products
Manufacturer shall achieve a new Reduced Testing Allowance.
I.
Violation
Affecting Public Safety. Failure to comply with this Rule may
constitute a license violation affecting public safety.
Notes
1
CCR 212-3-4-125
42
CR 23, December 10, 2019, effective
1/1/2020
43
CR 21, November 10, 2020, effective
1/1/2021
44
CR 07, April 10, 2021, effective
5/1/2021
44
CR 13, July 10, 2021, effective
8/1/2021
44
CR 23, December 10, 2021, effective
1/1/2022
45
CR 21, November 10, 2022, effective
12/1/2022
46
CR 23, December 10, 2023, effective
1/8/2024